Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

The term “antimicrobial stewardship” was first described in 1996 by John E. McGowan Jr., MD, and Dale N. Gerding, MD. Today, antimicrobial stewardship can be found in many different settings ...

Livestock manure around the globe is packed with antibiotic resistance genes (ARGs) that could threaten human health, ...

Antimicrobial stewardship in healthcare settings Stewardship in healthcare. The Agency for Healthcare Research and Quality has established the ‘Four Moments of Antibiotic Decision Making’ to ...

Results. Outcomes associated with antimicrobial stewardship interventions are summarized in Table 1, Table 2 and Table 3.A total of 36 studies were identified from the time period of interest and ...

An infectious diseases human clinician at the University of Colorado School of Medicine offered a unique perspective on antimicrobial stewardship at the 2025 ACVIM Forum in Louisville, Kentucky ...

This handbook provides a comprehensive overview of the emergence and progression of antimicrobial stewardship in US healthcare today. It is specially designed to offer insight for healthcare ...

"Arkstone and Neslab to introduce antimicrobial stewardship solutions across Peru" was originally created and published by ...

Antimicrobial stewardship (AMS) involves a set of actions that ensure optimal use of antimicrobials to improve patient outcomes, while reducing antimicrobial resistance (AMR).

John Dempsey Hospital an 'Antimicrobial Stewardship Center of Excellence' A commitment to responsible use of antibiotics ...

Antimicrobial stewardship interventions and patient reviews should not exclude patients receiving end-of-life care as the risks and harms of broad antimicrobial use in this subpopulation remain ...